A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib

Published:2016-03-11 Issue:6 Volume:72 Page:719-723
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Atiq Ferdows,Broers Annoek E C,Andrews Louise M,Doorduijn Jeanette K,Koch Birgit C P,Van Gelder Teun,Versmissen Jorie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-016-2038-9.pdf

Reference17 articles.

1. Beauchesne PR, Chung NS, Wasan KM (2007) Cyclosporine A: a review of current oral and intravenous delivery systems. Drug Development and Industrial Pharmacy 33(3):211–220. doi: 10.1080/03639040601155665

2. Lugo TG, Pendergast AM, Muller AJ, Witte ON (1990) Tyrosine kinase activity and transformation potency of BCR-ABL oncogene products. Science (New York, NY) 247(4946):1079–1082

3. Haouala A, Widmer N, Duchosal MA, Montemurro M, Buclin T, Decosterd LA (2011) Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. Blood 117(8):e75–e87. doi: 10.1182/blood-2010-07-294330

4. Capdeville R, Buchdunger E, Zimmermann J, Matter A (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1(7):493–502. doi: 10.1038/nrd839

5. Carpenter PA, Snyder DS, Flowers ME, Sanders JE, Gooley TA, Martin PJ, Appelbaum FR, Radich JP (2007) Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia. Blood 109(7):2791–2793. doi: 10.1182/blood-2006-04-019836

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia;Precision Medicine;2023

2. Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience;Pharmacology Research & Perspectives;2022-09-14

3. Unresectable GIST liver metastases and liver transplantation: A review and theoretical basis for a new indication;International Journal of Surgery;2021-10

4. Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review;FARM HOSP;2021

5. Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia;Frontiers in Pharmacology;2021-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3